health care provider

BioXcel Therapeutics BXCL501 demonstrated a significant mean reduction in mCGI-S score from baseline compared to placebo at 2…

BioXcel Therapeutics Company to host conference call at 8 a.m. ET, August 27, 2025 NEW HAVEN, Conn., Aug.…

BioXcel Therapeutics Data from more than 2,600 agitation episodes collected Topline data readout is on track for August …

Chia seeds, legumes and Greek yogurt are taking over TikTok as part of a new trend called “fibermaxxing.”…

BioXcel Therapeutics Reports Positive Topline Exploratory Efficacy Data from SERENITY At-Home Pivotal Phase 3 Safety Trial for Agitation Associated with Bipolar Disorders or Schizophrenia